Min Jung Ko

Min Jung Ko


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
JCJonggi Choi
Jonggi Choi
HKHyo Jeong Kim
Hyo Jeong Kim
JLJayoun Lee
Jayoun Lee
SCSonghee Cho
Songhee Cho
MKMin Jung Ko
Min Jung Ko
YLYoung-Suk Lim
Young-Suk Lim
Chronic hepatitis B (CHB) infection is the most common chronic viral infection worldwide, with approximately 250 million people carrying hepatitis B virus (HBV).1,2 Hepatitis B virus accounts for approximately 45% of cases of hepatocellular carcinoma (HCC) and 30% of cases of cirrhosis3 and causes nearly 1 million deaths each year.4

1 January 2021 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
MKMin Jung Ko
Min Jung Ko
DPDong Ah Park
Dong Ah Park
SKSung Hyun Kim
Sung Hyun Kim
EKEun Sook Ko
Eun Sook Ko
KSKyunghwan Shin
Kyunghwan Shin
JCJung Min Chang
Jung Min Chang
Ko MJ, et al. Korean J Radiol. 2021 Aug;22(8):1240-1252. https://doi.org/10.3348/kjr.2020.1227

9 July 2021 in Liver International
Verified
Journal Article
Closed access
PDF file
WCWon-Mook Choi
Won-Mook Choi
HKHyo Jeong Kim
Hyo Jeong Kim
AJAe Jeong Jo
Ae Jeong Jo
SCSo Hyun Choi
So Hyun Choi
SHSeungbong Han
Seungbong Han
YLYoung‐Suk Lim
Young‐Suk Lim

26 January 2024 in The Korean Journal of Orthodontics
Verified
Journal Article
Open access
PDF file
YKYoon-ji Kim
Yoon-ji Kim
MKMOON YOUNG Kim
MOON YOUNG Kim
NJNayansi Jha
Nayansi Jha
MJMin-Ho Jung
Min-Ho Jung
YKYong-Dae Kwon
Yong-Dae Kwon
SJSang Ho Jun
Sang Ho Jun
Yoon-Ji Kim, Moon-Young Kim, Nayansi Jha, Min-Ho Jung, Yong-Dae Kwon, Ho Gyun Shin, Min Jung Ko, Sang Ho Jun. Korean J Orthod 2024;54:89-107. https://doi.org/10.4041/kjod23.194

15 September 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
JAJiHyun An
JiHyun An
DPDong Ah Park
Dong Ah Park
MKMin Jung Ko
Min Jung Ko
SASang Bong Ahn
Sang Bong Ahn
JYJeong-Ju Yoo
Jeong-Ju Yoo
SYSun Young Yim
Sun Young Yim
DAA therapy is known to clear hepatitis C virus infection in patients with decompensated cirrhosis (DC). However, the safety and benefits of DAA in DC remain unclear, especially with the use of protease inhibitors (PI). Therefore, we evaluated the efficacy and clinical safety of DAA in DC patients and observed whether there was a discrepancy between PI-based and non-PI-based treatment. We searched Ovid-Medline, Ovid-EMBASE, Cochrane Library, and three local medical databases through October 2021 to identify relevant studies on the clinical safety and effectiveness of DAA in DC patients. The outcomes were sustained virologic response (SVR), overall mortality, the incidence rate of hepatocellular carcinoma (HCC), adverse events, improvement or deterioration of liver function, and delisting from liver transplantation (LT). Two independent reviewers extracted the data from each study using a standardized form. The pooled event rate in DC patients and relative effect (odds ratio (OR)) of PI-treated versus non-PI-based DAA in DC patients were calculated using a random-effects model. In patients with DC, the SVR rate was 86% (95% CI 83–88%), the development of HCC 7% (95% CI 5–9%), and mortality 6% (95% CI 4–8%). Improvement in liver function was observed in 51% (95% CI 44–58%) of patients, and 16% (95% CI 5–40%) were delisted from LT. PI-based treatment showed a similar rate of serious adverse events (23% vs. 18%), HCC occurrence (5% vs. 7%), and mortality (5% vs. 6%) to that of non-PI-based DAA treatment in DC patients. HCC occurrence and mortality rates were low in patients with DC following DAA treatment. PI-based treatment in DC patients was relatively safe when compared to non-PI-based treatment. Overall, DAA improved liver function, which may have allowed for delisting from LT.

13 October 2020 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
JLJayoun Lee
Jayoun Lee
SCSonghee Cho
Songhee Cho
HKHyo Jeong Kim
Hyo Jeong Kim
HLHangil Lee
Hangil Lee
MKMin Jung Ko
Min Jung Ko
YLYoung‐Suk Lim
Young‐Suk Lim